Neuren Pharmaceuticals price target lifted 2% to A$33.29
Neuren Pharmaceuticals’ price target was raised 2% to A$33.29 per share by Petra Capital.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.